Evaxion A/S
Copenhagen, Capital Region of Denmark, Denmark · Artificial Intelligence, Biotechnology, Health Care
Evaxion A/S is a clinical-stage TechBio company based in Copenhagen, Denmark. It specializes in developing AI-Immunology™ powered vaccines. The company focuses on addressing serious global medical issues through innovative vaccine candidates. Evaxion aims to harness the power of artificial intelligence to uncover novel vaccine targets.
Key facts
- Headquarters
- Copenhagen, Capital Region of Denmark, Denmark
- Employees
- 46
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Public (EVAX)
- Website
- evaxion.ai
- Company page
Recent activity at Evaxion A/S
Evaxion A/S in the news
- Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery? - Yahoo Finance (Aug 20, 2026)
- Danish Biotechs Attracting Investor Attention - PharmTech.com (Aug 10, 2026)
- Evaxion offloads vaccine candidate to Merck for $592M biobucks - Fierce Biotech (Sep 25, 2025)
- Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 - News-Medical (Jul 14, 2026)
- Evaxion (Nasdaq:EVAX) - Stock Analysis - simplywall.st (May 16, 2025)
- Using AI to create a vaccine revolution | Biopharma Dealmakers - Nature (May 18, 2023)
- Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025 (NASDAQ:EVAX) - Seeking Alpha (May 26, 2025)
- Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end - Fierce Biotech (Sep 26, 2024)
Companies similar to Evaxion A/S
- Rezo Therapeutics · Artificial Intelligence, Biotechnology, Health Care, research
- Algorae Pharmaceuticals · Artificial Intelligence, Biotechnology, Health Care, research
- Hepta · Artificial Intelligence, Biotechnology, Health Care, research
- ImpriMed · Artificial Intelligence, Biotechnology, Health Care
- Carebot · Artificial Intelligence, Biotechnology, Health Care
About Evaxion A/S: questions and answers
What does Evaxion A/S do?
Evaxion A/S is a clinical-stage TechBio company based in Copenhagen, Denmark. It specializes in developing AI-Immunology™ powered vaccines. The company focuses on addressing serious global medical issues through innovative vaccine candidates. Evaxion aims to harness the power of artificial intelligence to uncover novel vaccine targets.
Where is Evaxion A/S headquartered?
Evaxion A/S is headquartered in Copenhagen, Capital Region of Denmark, Denmark.
How many employees does Evaxion A/S have?
Evaxion A/S has about 46 employees.
What is the latest news on Evaxion A/S?
On Sep 25, 2025, Evaxion signs option and license agreement with MSD for vaccine candidate EVX-B3.
Is Evaxion A/S a public company?
Yes. Evaxion A/S is publicly traded under the ticker EVAX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy